{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:41:15Z","timestamp":1791855675363,"version":"4.3.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Buoniconti Fund and The Miami Project to Cure Paralysis","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"The Miami Project to Cure Paralysis","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"The Miami Project to Cure Paralysis","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"The National Cancer Institute (NCI) of the National Institutes of Health","award":["P30CA240139"],"award-info":[{"award-number":["P30CA240139"]}]},{"name":"State of Florida Department of Health Bankhead-Coley Cancer Research Program","award":["FL DOH 8BC09"],"award-info":[{"award-number":["FL DOH 8BC09"]}]},{"name":"The Flow Cytometry Shared Resource (FCSR) of the Sylvester Comprehensive Cancer Center at the University of Miami","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"The Buoniconti Fund and The Miami Project to Cure Paralysis and The John M. and Jocelyn H.K. Watkins Distinguished Chair in Cell Therapies","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02135-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:45:30Z","timestamp":1766519130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Removal or inhibition of transglutaminase 2 decreases cellular stress, supporting tissue preservation, and recovery after SCI"],"prefix":"10.1186","volume":"14","author":[{"given":"Mousumi","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elwardany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Jacqueline","family":"Saigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien D.","family":"Pearse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"2135_CR1","doi-asserted-by":"publisher","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","volume":"3","author":"CS Ahuja","year":"2017","unstructured":"Ahuja CS et al (2017) Traumatic spinal cord injury. Nat Rev Dis Primers 3:17018","journal-title":"Nat Rev Dis Primers"},{"key":"2135_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00282","volume":"10","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S (2019) Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol 10:282","journal-title":"Front Neurol"},{"issue":"1","key":"2135_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3171\/jns.1991.75.1.0015","volume":"75","author":"CH Tator","year":"1991","unstructured":"Tator CH, Fehlings MG (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75(1):15\u201326","journal-title":"J Neurosurg"},{"key":"2135_CR4","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12056","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Acute spinal cord injury: pathophysiology and pharmacological intervention (Review). Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12056","journal-title":"Mol Med Rep"},{"issue":"2","key":"2135_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.55782\/ane-2011-1848","volume":"71","author":"CA Oyinbo","year":"2011","unstructured":"Oyinbo CA (2011) Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp (Wars) 71(2):281\u2013299","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"5","key":"2135_CR6","doi-asserted-by":"publisher","DOI":"10.3171\/FOC.2008.25.11.E2","volume":"25","author":"JW Rowland","year":"2008","unstructured":"Rowland JW et al (2008) Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 25(5):E2","journal-title":"Neurosurg Focus"},{"issue":"2","key":"2135_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrn1326","volume":"5","author":"J Silver","year":"2004","unstructured":"Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5(2):146\u2013156","journal-title":"Nat Rev Neurosci"},{"issue":"4\u20135","key":"2135_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.brainresbull.2010.06.015","volume":"84","author":"EJ Bradbury","year":"2011","unstructured":"Bradbury EJ, Carter LM (2011) Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84(4\u20135):306\u2013316","journal-title":"Brain Res Bull"},{"issue":"3","key":"2135_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s13311-018-0631-6","volume":"15","author":"MB Orr","year":"2018","unstructured":"Orr MB, Gensel JC (2018) Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics 15(3):541\u2013553","journal-title":"Neurotherapeutics"},{"issue":"15","key":"2135_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/neu.2014.3703","volume":"32","author":"Y Zhu","year":"2015","unstructured":"Zhu Y et al (2015) Fibronectin matrix assembly after spinal cord injury. J Neurotrauma 32(15):1158\u20131167","journal-title":"J Neurotrauma"},{"key":"2135_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061241","author":"DD Pearse","year":"2022","unstructured":"Pearse DD et al (2022) Comparative profiling of TG2 and its effectors in human relapsing remitting and progressive multiple sclerosis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10061241","journal-title":"Biomedicines"},{"issue":"10","key":"2135_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","volume":"27","author":"L Fesus","year":"2002","unstructured":"Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27(10):534\u2013539","journal-title":"Trends Biochem Sci"},{"issue":"2\u20133","key":"2135_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00726-011-1008-x","volume":"42","author":"Z Wang","year":"2012","unstructured":"Wang Z, Griffin M (2012) TG2, a novel extracellular protein with multiple functions. Amino Acids 42(2\u20133):939\u2013949","journal-title":"Amino Acids"},{"issue":"4","key":"2135_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00726-008-0190-y","volume":"36","author":"RJ Collighan","year":"2009","unstructured":"Collighan RJ, Griffin M (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36(4):659\u2013670","journal-title":"Amino Acids"},{"issue":"24","key":"2135_CR15","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1111\/j.1742-4658.2011.08346.x","volume":"278","author":"AM Belkin","year":"2011","unstructured":"Belkin AM (2011) Extracellular TG2: emerging functions and regulation. FEBS J 278(24):4704\u20134716","journal-title":"FEBS J"},{"key":"2135_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/9781118105771.ch2","volume":"78","author":"V Gentile","year":"2011","unstructured":"Gentile V (2011) Physiopathological roles of human transglutaminase 2. Adv Enzymol Relat Areas Mol Biol 78:47\u201395","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"2135_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neuroscience.2020.11.034","volume":"461","author":"DD Pearse","year":"2021","unstructured":"Pearse DD et al (2021) Neuronal and endothelial transglutaminase-2 expression during experimental autoimmune encephalomyelitis and multiple sclerosis. Neuroscience 461:140\u2013154","journal-title":"Neuroscience"},{"issue":"1","key":"2135_CR18","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s42003-024-06672-x","volume":"7","author":"C Aplin","year":"2024","unstructured":"Aplin C et al (2024) Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death. Commun Biol 7(1):982","journal-title":"Commun Biol"},{"key":"2135_CR19","first-page":"1","volume":"294","author":"MV Nurminskaya","year":"2012","unstructured":"Nurminskaya MV, Belkin AM (2012) Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol 294:1\u201397","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"2135_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1152\/physrev.00003.2023","volume":"104","author":"Z Yao","year":"2024","unstructured":"Yao Z et al (2024) Tissue transglutaminase: a multifunctional and multisite regulator in health and disease. Physiol Rev 104(1):281\u2013325","journal-title":"Physiol Rev"},{"issue":"21","key":"2135_CR21","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1111\/febs.13907","volume":"283","author":"J Stamnaes","year":"2016","unstructured":"Stamnaes J et al (2016) Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain. FEBS J 283(21):3994\u20134010","journal-title":"FEBS J"},{"issue":"9","key":"2135_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14728222.2021.1989410","volume":"25","author":"JW Keillor","year":"2021","unstructured":"Keillor JW, Johnson GVW (2021) Transglutaminase 2 as a therapeutic target for neurological conditions. Expert Opin Ther Targets 25(9):721\u2013731","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"2135_CR23","doi-asserted-by":"publisher","first-page":"e2244","DOI":"10.1038\/cddis.2016.150","volume":"7","author":"H Tatsukawa","year":"2016","unstructured":"Tatsukawa H et al (2016) Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death. Cell Death Dis 7(6):e2244","journal-title":"Cell Death Dis"},{"key":"2135_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041897","author":"T Su","year":"2021","unstructured":"Su T, Qin XY, Furutani Y (2021) Transglutaminase 2 as a marker for inflammation and therapeutic target in sepsis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041897","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2135_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3371","volume":"15","author":"N Agnihotri","year":"2013","unstructured":"Agnihotri N, Kumar S, Mehta K (2013) Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer. Breast Cancer Res 15(1):202","journal-title":"Breast Cancer Res"},{"key":"2135_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155024","volume":"128","author":"C Sestito","year":"2020","unstructured":"Sestito C et al (2020) Tissue transglutaminase contributes to myelin phagocytosis in interleukin-4-treated human monocyte-derived macrophages. Cytokine 128:155024","journal-title":"Cytokine"},{"issue":"1","key":"2135_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1031-2","volume":"14","author":"N Espitia Pinzon","year":"2017","unstructured":"Espitia Pinzon N et al (2017) Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures. J Neuroinflammation 14(1):260","journal-title":"J Neuroinflammation"},{"key":"2135_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2019.113556","volume":"591","author":"J Rudlong","year":"2020","unstructured":"Rudlong J, Cheng A, Johnson GVW (2020) The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system. Anal Biochem 591:113556","journal-title":"Anal Biochem"},{"key":"2135_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbi.2015.06.023","volume":"50","author":"ME van Strien","year":"2015","unstructured":"van Strien ME et al (2015) Tissue transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration. Brain Behav Immun 50:141\u2013154","journal-title":"Brain Behav Immun"},{"issue":"6","key":"2135_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnen\/nlz030","volume":"78","author":"NL Chrobok","year":"2019","unstructured":"Chrobok NL et al (2019) Tissue transglutaminase appears in monocytes and macrophages but not in lymphocytes in white matter multiple sclerosis lesions. J Neuropathol Exp Neurol 78(6):492\u2013500","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2135_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5483\/BMBRep.2018.51.1.227","volume":"51","author":"B Min","year":"2018","unstructured":"Min B, Chung KC (2018) New insight into transglutaminase 2 and link to neurodegenerative diseases. BMB Rep 51(1):5\u201313","journal-title":"BMB Rep"},{"key":"2135_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuroscience.2020.05.047","volume":"441","author":"J Zhang","year":"2020","unstructured":"Zhang J et al (2020) Transglutaminase 2 depletion attenuates alpha-synuclein mediated toxicity in mice. Neuroscience 441:58\u201364","journal-title":"Neuroscience"},{"issue":"2","key":"2135_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/SLA.0b013e31822645b4","volume":"254","author":"R Hu","year":"2011","unstructured":"Hu R et al (2011) Role of acid-sensing ion channel 1a in the secondary damage of traumatic spinal cord injury. Ann Surg 254(2):353\u2013362","journal-title":"Ann Surg"},{"key":"2135_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114596","volume":"162","author":"J Panes-Fernandez","year":"2023","unstructured":"Panes-Fernandez J et al (2023) TG2 promotes amyloid beta aggregates: impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer\u2019s disease. Biomed Pharmacother 162:114596","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"2135_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/emmm.201000084","volume":"2","author":"SJ McConoughey","year":"2010","unstructured":"McConoughey SJ et al (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med 2(9):349\u2013370","journal-title":"EMBO Mol Med"},{"key":"2135_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080667","author":"M Buccarelli","year":"2024","unstructured":"Buccarelli M et al (2024) Biological implications and functional significance of transglutaminase type 2 in nervous system tumors. Cells. https:\/\/doi.org\/10.3390\/cells13080667","journal-title":"Cells"},{"key":"2135_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042364","author":"J Liu","year":"2024","unstructured":"Liu J, Mouradian MM (2024) Pathogenetic contributions and therapeutic implications of transglutaminase 2 in neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25042364","journal-title":"Int J Mol Sci"},{"key":"2135_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112942","author":"A Elahi","year":"2021","unstructured":"Elahi A et al (2021) Deletion or inhibition of astrocytic transglutaminase 2 promotes functional recovery after spinal cord injury. Cells. https:\/\/doi.org\/10.3390\/cells10112942","journal-title":"Cells"},{"issue":"3","key":"2135_CR39","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.nbd.2011.12.023","volume":"45","author":"G Colak","year":"2012","unstructured":"Colak G, Johnson GV (2012) Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Neurobiol Dis 45(3):1042\u20131050","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2135_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00726-008-0130-x","volume":"36","author":"Z Sarang","year":"2009","unstructured":"Sarang Z et al (2009) Some lessons from the tissue transglutaminase knockout mouse. Amino Acids 36(4):625\u2013631","journal-title":"Amino Acids"},{"issue":"10","key":"2135_CR41","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.4049\/jimmunol.2001122","volume":"206","author":"L Occhigrossi","year":"2021","unstructured":"Occhigrossi L et al (2021) Transglutaminase 2 regulates innate immunity by modulating the STING\/TBK1\/IRF3 axis. J Immunol 206(10):2420\u20132429","journal-title":"J Immunol"},{"issue":"12","key":"2135_CR42","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16012","volume":"12","author":"MAT Freeberg","year":"2024","unstructured":"Freeberg MAT et al (2024) Transglutaminase 2 knockout mice are protected from bleomycin-induced lung fibrosis with preserved lung function and reduced metabolic derangements. Physiol Rep 12(12):e16012","journal-title":"Physiol Rep"},{"issue":"2","key":"2135_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2012.08.009","volume":"145","author":"K Oh","year":"2012","unstructured":"Oh K et al (2012) Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation. Clin Immunol 145(2):122\u2013132","journal-title":"Clin Immunol"},{"issue":"13","key":"2135_CR44","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.celrep.2018.11.094","volume":"25","author":"M D'Eletto","year":"2018","unstructured":"D\u2019Eletto M et al (2018) Transglutaminase type 2 regulates ER-mitochondria contact sites by interacting with GRP75. Cell Rep 25(13):3573\u20133581","journal-title":"Cell Rep"},{"issue":"3","key":"2135_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/jcp.22833","volume":"227","author":"TF Kuo","year":"2012","unstructured":"Kuo TF et al (2012) Free fatty acids induce transglutaminase 2-dependent apoptosis in hepatocytes via ER stress-stimulated PERK pathways. J Cell Physiol 227(3):1130\u20131137","journal-title":"J Cell Physiol"},{"key":"2135_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021495","author":"S Sposito","year":"2023","unstructured":"Sposito S et al (2023) Peculiar Ca(2+) homeostasis, ER stress, autophagy, and TG2 modulation in celiac disease patient-derived cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021495","journal-title":"Int J Mol Sci"},{"issue":"18","key":"2135_CR47","doi-asserted-by":"publisher","first-page":"14377","DOI":"10.1074\/jbc.M111.326074","volume":"287","author":"JO Yoo","year":"2012","unstructured":"Yoo JO et al (2012) Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain\/Bax protein signaling pathway. J Biol Chem 287(18):14377\u201314388","journal-title":"J Biol Chem"},{"issue":"8","key":"2135_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrneurol.2017.99","volume":"13","author":"C Hetz","year":"2017","unstructured":"Hetz C, Saxena S (2017) ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol 13(8):477\u2013491","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"2135_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sc.2014.91","volume":"52","author":"T Cheriyan","year":"2014","unstructured":"Cheriyan T et al (2014) Spinal cord injury models: a review. Spinal Cord 52(8):588\u2013595","journal-title":"Spinal Cord"},{"issue":"3","key":"2135_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/neu.2015.3937","volume":"33","author":"G Moonen","year":"2016","unstructured":"Moonen G et al (2016) A new acute impact-compression lumbar spinal cord injury model in the rodent. J Neurotrauma 33(3):278\u2013289","journal-title":"J Neurotrauma"},{"issue":"12","key":"2135_CR51","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/jnr.25120","volume":"100","author":"R Ridlen","year":"2022","unstructured":"Ridlen R, McGrath K, Gorrie CA (2022) Animal models of compression spinal cord injury. J Neurosci Res 100(12):2201\u20132212","journal-title":"J Neurosci Res"},{"issue":"15","key":"2135_CR52","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1089\/neu.2016.4915","volume":"34","author":"MB Orr","year":"2017","unstructured":"Orr MB et al (2017) Compression decreases anatomical and functional recovery and alters inflammation after contusive spinal cord injury. J Neurotrauma 34(15):2342\u20132352","journal-title":"J Neurotrauma"},{"key":"2135_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020245","author":"DM Maggio","year":"2017","unstructured":"Maggio DM et al (2017) Identifying the long-term role of inducible nitric oxide synthase after contusive spinal cord injury using a transgenic mouse model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18020245","journal-title":"Int J Mol Sci"},{"issue":"24","key":"2135_CR54","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1021\/acs.biochem.8b00204","volume":"57","author":"BA Palanski","year":"2018","unstructured":"Palanski BA, Khosla C (2018) Cystamine and disulfiram inhibit human transglutaminase 2 via an oxidative mechanism. Biochemistry 57(24):3359\u20133363","journal-title":"Biochemistry"},{"issue":"6","key":"2135_CR55","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.neurobiolaging.2005.04.004","volume":"27","author":"ME Tremblay","year":"2006","unstructured":"Tremblay ME et al (2006) Neuroprotective effects of cystamine in aged parkinsonian mice. Neurobiol Aging 27(6):862\u2013870","journal-title":"Neurobiol Aging"},{"issue":"20","key":"2135_CR56","doi-asserted-by":"publisher","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A et al (2002) Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease. J Neurosci 22(20):8942\u20138950","journal-title":"J Neurosci"},{"issue":"5","key":"2135_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","volume":"23","author":"DM Basso","year":"2006","unstructured":"Basso DM et al (2006) Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23(5):635\u2013659","journal-title":"J Neurotrauma"},{"key":"2135_CR58","first-page":"1204","volume":"28","author":"GA Metz","year":"2009","unstructured":"Metz GA, Whishaw IQ (2009) The ladder rung walking task: a scoring system and its practical application. J Visual Exp: JoVE. 28:1204","journal-title":"J Visual Exp: JoVE."},{"issue":"6","key":"2135_CR59","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/glia.22330","volume":"60","author":"M Ghosh","year":"2012","unstructured":"Ghosh M et al (2012) Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury. Glia 60(6):979\u2013992","journal-title":"Glia"},{"issue":"2","key":"2135_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neures.2010.02.009","volume":"67","author":"A Pajoohesh-Ganji","year":"2010","unstructured":"Pajoohesh-Ganji A et al (2010) A combined scoring method to assess behavioral recovery after mouse spinal cord injury. Neurosci Res 67(2):117\u2013125","journal-title":"Neurosci Res"},{"issue":"15","key":"2135_CR61","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1089\/neu.2014.3702","volume":"32","author":"JP Datto","year":"2015","unstructured":"Datto JP et al (2015) Female rats demonstrate improved locomotor recovery and greater preservation of white and gray matter after traumatic spinal cord injury compared to males. J Neurotrauma 32(15):1146\u20131157","journal-title":"J Neurotrauma"},{"issue":"9","key":"2135_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043634","volume":"7","author":"SM Schaal","year":"2012","unstructured":"Schaal SM et al (2012) The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury. PLoS ONE 7(9):e43634","journal-title":"PLoS ONE"},{"key":"2135_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070645","author":"M Ghosh","year":"2024","unstructured":"Ghosh M et al (2024) Sex dependent disparities in the central innate immune response after moderate spinal cord contusion in rat. Cells. https:\/\/doi.org\/10.3390\/cells13070645","journal-title":"Cells"},{"key":"2135_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122345","author":"V Ngo","year":"2022","unstructured":"Ngo V, Duennwald ML (2022) Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11122345","journal-title":"Antioxidants"},{"key":"2135_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102347","volume":"54","author":"S Kim","year":"2022","unstructured":"Kim S et al (2022) The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic stroke. Redox Biol 54:102347","journal-title":"Redox Biol"},{"key":"2135_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","volume":"226","author":"IM Ibrahim","year":"2019","unstructured":"Ibrahim IM, Abdelmalek DH, Elfiky AA (2019) GRP78: a cell\u2019s response to stress. Life Sci 226:156\u2013163","journal-title":"Life Sci"},{"issue":"12","key":"2135_CR67","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1021\/jm100054f","volume":"53","author":"CG Evans","year":"2010","unstructured":"Evans CG, Chang L, Gestwicki JE (2010) Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 53(12):4585\u20134602","journal-title":"J Med Chem"},{"issue":"2","key":"2135_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10545-009-1061-8","volume":"32","author":"ML Oppenheim","year":"2009","unstructured":"Oppenheim ML et al (2009) Mitochondrial cytochrome c release: a factor to consider in mitochondrial disease? J Inherit Metab Dis 32(2):269\u2013273","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2135_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q et al (2024) NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9(1):53","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2135_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107(1):7\u201311","journal-title":"J Clin Invest"},{"issue":"4","key":"2135_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1(4):a000034","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2135_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847699","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H et al (2022) Bcl-3: a double-edged sword in immune cells and inflammation. Front Immunol 13:847699","journal-title":"Front Immunol"},{"issue":"1","key":"2135_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2012.10.011","volume":"1833","author":"S Gundemir","year":"2013","unstructured":"Gundemir S et al (2013) Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochim Biophys Acta 1833(1):1\u201310","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"2135_CR74","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1111\/j.1742-4658.2011.08409.x","volume":"278","author":"TF Kuo","year":"2011","unstructured":"Kuo TF, Tatsukawa H, Kojima S (2011) New insights into the functions and localization of nuclear transglutaminase 2. FEBS J 278(24):4756\u20134767","journal-title":"FEBS J"},{"issue":"3","key":"2135_CR75","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/onc.2009.342","volume":"29","author":"GY Jang","year":"2010","unstructured":"Jang GY et al (2010) Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. Oncogene 29(3):356\u2013367","journal-title":"Oncogene"},{"issue":"52","key":"2135_CR76","doi-asserted-by":"publisher","first-page":"54783","DOI":"10.1074\/jbc.M410938200","volume":"279","author":"C Rodolfo","year":"2004","unstructured":"Rodolfo C et al (2004) Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 279(52):54783\u201354792","journal-title":"J Biol Chem"},{"issue":"3","key":"2135_CR77","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","volume":"11","author":"D Verzella","year":"2020","unstructured":"Verzella D et al (2020) Life, death, and autophagy in cancer: NF-kappaB turns up everywhere. Cell Death Dis 11(3):210","journal-title":"Cell Death Dis"},{"issue":"2","key":"2135_CR78","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2005.11.071","volume":"339","author":"S Mishra","year":"2006","unstructured":"Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339(2):726\u2013730","journal-title":"Biochem Biophys Res Commun"},{"key":"2135_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071842","author":"H Tatsukawa","year":"2021","unstructured":"Tatsukawa H, Hitomi K (2021) Role of transglutaminase 2 in cell death, survival, and fibrosis. Cells. https:\/\/doi.org\/10.3390\/cells10071842","journal-title":"Cells"},{"issue":"3","key":"2135_CR80","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00726-016-2334-9","volume":"49","author":"NL Chrobok","year":"2017","unstructured":"Chrobok NL et al (2017) Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes? Amino Acids 49(3):441\u2013452","journal-title":"Amino Acids"},{"key":"2135_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076058","author":"J Emerson","year":"2023","unstructured":"Emerson J et al (2023) Deletion of transglutaminase 2 from mouse astrocytes significantly improves their ability to promote neurite outgrowth on an inhibitory matrix. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076058","journal-title":"Int J Mol Sci"},{"key":"2135_CR82","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201745067","author":"F Rossin","year":"2018","unstructured":"Rossin F et al (2018) TG2 regulates the heat-shock response by the post-translational modification of HSF1. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201745067","journal-title":"EMBO Rep"},{"issue":"2\u20133","key":"2135_CR83","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00726-011-1018-8","volume":"42","author":"D Caccamo","year":"2012","unstructured":"Caccamo D et al (2012) Monitoring of transglutaminase 2 under different oxidative stress conditions. Amino Acids 42(2\u20133):1037\u20131043","journal-title":"Amino Acids"},{"key":"2135_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1330678","volume":"15","author":"Z Yin","year":"2024","unstructured":"Yin Z et al (2024) ROS: executioner of regulating cell death in spinal cord injury. Front Immunol 15:1330678","journal-title":"Front Immunol"},{"issue":"1","key":"2135_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sc.2013.118","volume":"52","author":"D Matsuyama","year":"2014","unstructured":"Matsuyama D et al (2014) Endoplasmic reticulum stress response in the rat contusive spinal cord injury model-susceptibility in specific cell types. Spinal Cord 52(1):9\u201316","journal-title":"Spinal Cord"},{"key":"2135_CR86","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuroscience.2022.06.007","volume":"498","author":"X Guo","year":"2022","unstructured":"Guo X et al (2022) Nrf2 signaling in the oxidative stress response after spinal cord injury. Neuroscience 498:311\u2013324","journal-title":"Neuroscience"},{"key":"2135_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162503","author":"C Munteanu","year":"2022","unstructured":"Munteanu C et al (2022) Main cations and cellular biology of traumatic Spinal Cord Injury. Cells. https:\/\/doi.org\/10.3390\/cells11162503","journal-title":"Cells"},{"key":"2135_CR88","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cca.2020.02.024","volume":"506","author":"A Gao","year":"2020","unstructured":"Gao A et al (2020) Bnip3 in mitophagy: novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction. Clin Chim Acta 506:72\u201383","journal-title":"Clin Chim Acta"},{"issue":"9","key":"2135_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox059","volume":"30","author":"Z Ma","year":"2017","unstructured":"Ma Z et al (2017) BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death. Dis Esophagus 30(9):1\u20138","journal-title":"Dis Esophagus"},{"issue":"17","key":"2135_CR90","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1523\/JNEUROSCI.0206-11.2011","volume":"31","author":"S Mincheva","year":"2011","unstructured":"Mincheva S et al (2011) The canonical nuclear factor-kappaB pathway regulates cell survival in a developmental model of spinal cord motoneurons. J Neurosci 31(17):6493\u20136503","journal-title":"J Neurosci"},{"issue":"3","key":"2135_CR91","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.RES.88.3.262","volume":"88","author":"R Lee","year":"2001","unstructured":"Lee R, Collins T (2001) Nuclear factor-kappaB and cell survival: IAPs call for support. Circ Res 88(3):262\u2013264","journal-title":"Circ Res"},{"key":"2135_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.05.009","volume":"1668","author":"J Feola","year":"2017","unstructured":"Feola J et al (2017) Transglutaminase 2 modulation of NF-kappaB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury. Brain Res 1668:1\u201311","journal-title":"Brain Res"},{"key":"2135_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.brainres.2008.10.035","volume":"1249","author":"M Okauchi","year":"2009","unstructured":"Okauchi M et al (2009) Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits. Brain Res 1249:229\u2013236","journal-title":"Brain Res"},{"issue":"2","key":"2135_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/hsz-2018-0217","volume":"400","author":"M D'Eletto","year":"2019","unstructured":"D\u2019Eletto M et al (2019) Transglutaminase type 2 in the regulation of proteostasis. Biol Chem 400(2):125\u2013140","journal-title":"Biol Chem"},{"key":"2135_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213339","author":"SR Whittemore","year":"2022","unstructured":"Whittemore SR et al (2022) The proteostasis network: a global therapeutic target for neuroprotection after spinal cord injury. Cells. https:\/\/doi.org\/10.3390\/cells11213339","journal-title":"Cells"},{"key":"2135_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411475","author":"TW Yiu","year":"2023","unstructured":"Yiu TW et al (2023) Transglutaminase 2 facilitates murine wound healing in a strain-dependent manner. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241411475","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2135_CR97","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1160\/TH14-07-0625","volume":"113","author":"G Dickneite","year":"2015","unstructured":"Dickneite G et al (2015) Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions. Thromb Haemost 113(4):686\u2013697","journal-title":"Thromb Haemost"},{"issue":"1","key":"2135_CR98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cellimm.2009.10.008","volume":"261","author":"IS Smirnova","year":"2010","unstructured":"Smirnova IS, Chang S, Forsthuber TG (2010) Prosurvival and proapoptotic functions of ERK1\/2 activation in murine thymocytes in vitro. Cell Immunol 261(1):29\u201336","journal-title":"Cell Immunol"},{"issue":"11","key":"2135_CR99","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/15216540600957438","volume":"58","author":"Z Lu","year":"2006","unstructured":"Lu Z, Xu S (2006) ERK1\/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58(11):621\u2013631","journal-title":"IUBMB Life"},{"issue":"8","key":"2135_CR100","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2741\/4291","volume":"19","author":"Q Li","year":"2014","unstructured":"Li Q et al (2014) The dual role of ERK signaling in the apoptosis of neurons. Front Biosci (Landmark Ed) 19(8):1411\u20131417","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"2135_CR101","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","volume":"277","author":"S Cagnol","year":"2010","unstructured":"Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death\u2013apoptosis, autophagy and senescence. FEBS J 277(1):2\u201321","journal-title":"FEBS J"},{"key":"2135_CR102","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180691","author":"TM Jeitner","year":"2018","unstructured":"Jeitner TM, Pinto JT, Cooper AJL (2018) Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20180691"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02135-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:03:49Z","timestamp":1769443429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2135"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02135-4","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20180691","asserted-by":"subject"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed according to the approved protocol by the Institutional Animal Care and Use Committee (IACUC) of University of Miami (IACUC protocol #19\u2013134). All applicable institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}